Phase III EVALUATE THE EFFICACY, SAFETY, PHARMACOKINETICS, AND PHARMACODYNAMICS OF SATRALIZUMAB
Clinical Trial Grant
Administered By
Pediatrics, Rheumatology
Awarded By
Genentech, Inc.
Start Date
April 9, 2025
End Date
August 1, 2026
Administered By
Pediatrics, Rheumatology
Awarded By
Genentech, Inc.
Start Date
April 9, 2025
End Date
August 1, 2026